All Comparisons/Layer Health vs Carta Healthcare

VNDRIQ — Vendor Comparison

Layer Health vs Carta Healthcare

Side-by-side comparison of BAA status, PHI exposure, AI training risk, HIPAA suitability, and VNDRIQ governance scores.

Layer Health35
Carta Healthcare82

Layer Health

Clinical Intelligence AI

Verification pending

Carta Healthcare

Clinical Intelligence AI

Last verified: August 31, 2026

VNDRIQ Scores

35

Overall

Privacy Score36
Governance Score37
Healthcare Readiness35
AI Risk Score30

82

Overall

Privacy Score68
Governance Score85
Healthcare Readiness83
AI Risk Score90

Approval Tier

Restricted / Review Required
Approved

BAA Status

Not Verified
Available upon request for healthcare clients

PHI Exposure Risk

High
Medium

AI Training Risk

High
Low

HIPAA Risk Level

High
Low

Review Frequency

Quarterly

Quarterly

Recommended Use

Clinical chart review, registry abstraction, and clinical documentation improvement.

Clinical data abstraction, registry management, and clinical data analysis.

Restrictions

Requires formal BAA verification and review of data usage policies for AI model training.

None specified, but requires standard BAA execution for PHI processing.

Executive Summary

Layer Health

Clinical Intelligence AI

Layer Health is classified as Restricted / Review Required with a BAA status of Not Verified. PHI exposure is rated High and AI training risk is High. Clinical chart review, registry abstraction, and clinical documentation improvement.

36

Privacy

37

Governance

35

Healthcare

30

AI Risk

Carta Healthcare

Clinical Intelligence AI

Carta Healthcare is classified as Approved with a BAA status of Available upon request for healthcare clients. PHI exposure is rated Medium and AI training risk is Low. Clinical data abstraction, registry management, and clinical data analysis.

68

Privacy

85

Governance

83

Healthcare

90

AI Risk

Recommended For

Layer Health

Clinical chart review, registry abstraction, and clinical documentation improvement.

Currently under review — not recommended for active PHI deployment

Carta Healthcare

Clinical data abstraction, registry management, and clinical data analysis.

Organizations with established governance workflows

Multi-location healthcare groups needing standardized vendor status

Governance Considerations

Layer Health

Verify model training opt-out clauses before deployment.

PHI exposure is elevated. Review data flow documentation.

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: Requires formal BAA verification and review of data usage policies for AI model training.

Carta Healthcare

Quarterly reviews are required — establish internal review cadence.

Restrictions noted: None specified, but requires standard BAA execution for PHI processing.

Questions to Ask Before Approval

01

Has the vendor executed a Business Associate Agreement (BAA) with your organization?

02

Does the vendor use customer data to train AI models? Can you opt out?

03

Where is PHI stored, processed, and transmitted?

04

What data retention and deletion policies apply to your PHI?

05

Has the vendor undergone a third-party HIPAA or SOC 2 audit?

06

What is the vendor's incident response and breach notification process?

07

Does the vendor offer audit logging for PHI access?

08

What subprocessors have access to PHI through this vendor?

Request Vendor Evaluation

Get a structured risk assessment for any vendor.

Request Benchmark Report

Compare vendors across your full stack.

Book Governance Assessment

Talk to a VNDRIQ governance specialist.